Importer of Controlled Substances Registration, 27632-27633 [2018-12670]

Download as PDF 27632 Federal Register / Vol. 83, No. 114 / Wednesday, June 13, 2018 / Notices Dated: June 1, 2018. Robert W. Patterson, Acting Administrator. applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before August 13, 2018. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. [FR Doc. 2018–12686 Filed 6–12–18; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] ACTION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, SUPPLEMENTARY INFORMATION: Bulk Manufacturer of Controlled Substances Application: Johnson Matthey Pharmaceutical Materials Inc. Notice of application. Registered bulk manufacturers of the affected basic classes, and DATES: incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on January 1, 2018, Johnson Matthey Pharmaceutical Materials Inc., 25 Patton Road, Devens, MA 01434 applied to be registered as a bulk manufacturer for the basic classes of controlled substances: Controlled substance Drug code Amphetamine ................................................................................................................................................................... Methylphenidate .............................................................................................................................................................. Nabilone ........................................................................................................................................................................... Hydrocodone ................................................................................................................................................................... Levorphanol ..................................................................................................................................................................... Alfentanil .......................................................................................................................................................................... Remifentanil ..................................................................................................................................................................... Sufentanil ......................................................................................................................................................................... The company plans to utilize this facility to manufacture small quantities of the listed controlled substances in bulk for distribution to its customers as well as to conduct analytical testing in support of the company’s primary manufacturing facility in West Deptford, New Jersey. DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Registration ACTION: Dated: June 6, 2018. John J. Martin, Assistant Administrator. Notice of registration. Registrants listed below have applied for and been granted registration by-the Drug Enforcement Administration (DEA) as importers of SUMMARY: [FR Doc. 2018–12685 Filed 6–12–18; 8:45 am] BILLING CODE 4410–09–P The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices. FR docket amozie on DSK3GDR082PROD with NOTICES1 18:01 Jun 12, 2018 Jkt 244001 protocols in effect on May 1, 1971. The DEA investigated each company’s maintenance of effective controls against diversion by inspecting and testing each company’s physical security systems, verifying each company’s compliance with state and local laws, and reviewing each company’s background and history. PO 00000 Frm 00095 Fmt 4703 Sfmt 4703 II II II II II II II II SUPPLEMENTARY INFORMATION: PerkinElmer, Inc ................................................................................................................................................... Stepan Company .................................................................................................................................................. Noramco, Inc ........................................................................................................................................................ Sanyal Biotechnology ........................................................................................................................................... S&B Pharma, Inc .................................................................................................................................................. Siegfried USA, LLC .............................................................................................................................................. Lannett Company, Inc .......................................................................................................................................... VerDate Sep<11>2014 1100 1724 7379 9193 9220 9737 9739 9740 various classes of schedule I or II controlled substances. Company The Drug Enforcement Administration (DEA) has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or Schedule 83 83 83 83 83 83 83 FR FR FR FR FR FR FR 9337 9337 12408 12407 13523 13521 13520 Published March March March March March March March 5, 2018. 5, 2018. 21, 2018. 21, 2018. 29, 2018. 29, 2018. 29, 2018. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I or II controlled substances to the above listed companies. E:\FR\FM\13JNN1.SGM 13JNN1 27633 Federal Register / Vol. 83, No. 114 / Wednesday, June 13, 2018 / Notices Dated: May 30, 2018. John J. Martin, Assistant Administrator. [FR Doc. 2018–12670 Filed 6–12–18; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Application: Cambrex Charles City ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before July 13, 2018. Such persons may also file a written request for a DATES: hearing on the application on or before July 13, 2018. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been delegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on March 10, 2018, Cambrex Charles City, 1205 11th Street, Charles City, IA 50616 applied to be registered as an importer of the following basic classes of controlled substances: Controlled substance Drug code 4-Anilino-N-phenethyl-4-piperidine (ANPP) ..................................................................................................................... Phenylacetone ................................................................................................................................................................. Coca Leaves .................................................................................................................................................................... Opium, raw ...................................................................................................................................................................... Poppy Straw Concentrate ............................................................................................................................................... The company plans to import the listed controlled substances for internal use, and to manufacture bulk intermediates for sale to its customers. Dated: June 6, 2018. John J. Martin, Assistant Administrator. [FR Doc. 2018–12683 Filed 6–12–18; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Application: Bellwyck Clinical Services ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the amozie on DSK3GDR082PROD with NOTICES1 DATES: issuance of the proposed registration on or before July 13, 2018. Such persons may also file a written request for a hearing on the application on or before July 13, 2018. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his Drug code Amphetamine ........................................................................................................................................................ Methylphenidate .................................................................................................................................................... Oxycodone ............................................................................................................................................................ 18:01 Jun 12, 2018 Jkt 244001 PO 00000 Frm 00096 Fmt 4703 8333 8501 9040 9600 9670 Sfmt 4703 II II II II II authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on April 4, 2018, Bellwyck Clinical Services, 8946 Global Way, West Chester, OH 45069 applied to be registered as an importer of the following basic classes of controlled substances: Controlled substance VerDate Sep<11>2014 Schedule E:\FR\FM\13JNN1.SGM 13JNN1 1100 1724 9143 Schedule II II II

Agencies

[Federal Register Volume 83, Number 114 (Wednesday, June 13, 2018)]
[Notices]
[Pages 27632-27633]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-12670]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Registrants listed below have applied for and been granted 
registration by-the Drug Enforcement Administration (DEA) as importers 
of various classes of schedule I or II controlled substances.

SUPPLEMENTARY INFORMATION: The companies listed below applied to be 
registered as importers of various basic classes of controlled 
substances. Information on previously published notices is listed in 
the table below. No comments or objections were submitted and no 
requests for hearing were submitted for these notices.

 
------------------------------------------------------------------------
           Company                  FR docket             Published
------------------------------------------------------------------------
PerkinElmer, Inc.............   83 FR 9337          March 5, 2018.
Stepan Company...............  83 FR 9337           March 5, 2018.
Noramco, Inc.................   83 FR 12408         March 21, 2018.
Sanyal Biotechnology.........  83 FR 12407          March 21, 2018.
S&B Pharma, Inc..............  83 FR 13523          March 29, 2018.
Siegfried USA, LLC...........  83 FR 13521           March 29, 2018.
Lannett Company, Inc.........  83 FR 13520          March 29, 2018.
------------------------------------------------------------------------

    The Drug Enforcement Administration (DEA) has considered the 
factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the 
registration of the listed registrants to import the applicable basic 
classes of schedule I or II controlled substances is consistent with 
the public interest and with United States obligations under 
international treaties, conventions, or protocols in effect on May 1, 
1971. The DEA investigated each company's maintenance of effective 
controls against diversion by inspecting and testing each company's 
physical security systems, verifying each company's compliance with 
state and local laws, and reviewing each company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the DEA has granted a registration as 
an importer for schedule I or II controlled substances to the above 
listed companies.


[[Page 27633]]


    Dated: May 30, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-12670 Filed 6-12-18; 8:45 am]
 BILLING CODE 4410-09-P